Capital Advisors, Ltd. LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital Advisors, Ltd. LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 51,989$79,543,0000.24%
ASSET MANAGEMENT CORP /IL/ /ADV 133,500$204,0000.10%
Ikarian Capital, LLC 553,273$847,0000.06%
McAdam, LLC 55,978$86,0000.01%
JGP Wealth Management, LLC 15,000$23,0000.01%
Fort Point Capital Partners LLC 10,000$15,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 55,599$85,0000.00%
Prospera Financial Services Inc 30,300$46,0000.00%
ExodusPoint Capital Management, LP 36,878$56,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 6,501$10,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders